Hookworm infections have a significant impact on global health, particularly in low-income countries with inadequate sanitation and hygiene. The World Health Organization (WHO) estimates that over a billion people worldwide are affected by soil-transmitted helminth infections, including hookworms. The burden of disease is substantial, contributing to malnutrition, impaired cognitive development, and reduced work productivity. Research efforts aim to understand the complex interactions between hookworms and the host immune system, as well as the mechanisms underlying the development of anemia and other clinical manifestations. Investigating host genetics, environmental factors, and the molecular biology of hookworms informs the development of targeted interventions and treatment strategies. n addition to anthelmintic drugs, research explores alternative approaches, such as vaccines, to prevent hookworm infections. Vaccine development faces challenges, including the genetic diversity of hookworm species and the complex lifecycle. However, progress is being made in identifying potential vaccine candidates that could provide long-lasting immunity. Global initiatives, such as the Soil-Transmitted Helminthiasis (STH) Coalition, bring together researchers, policymakers, and organizations to coordinate efforts in tackling hookworm infections and other soil-transmitted helminthiasis. These collaborations focus on scaling up preventive measures, improving access to treatment, and addressing the social determinants of hookworm transmission. Ultimately, the control of hookworm infections requires a multifaceted approach, including public health interventions, research advancements, and sustainable improvements in sanitation and living conditions. Efforts to combat hookworm infections align with broader global health goals, aiming to alleviate the burden of neglected tropical diseases and improve the well-being of affected populations.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : A rare case of meningitis and septicemia due to Streptococcus acidominimus
Percival C Dilla, Region II Trauma and Medical Center, Philippines
Title : Detection and variant characterization of lumpy skin disease virus (LSDV) from dairy cattle in India
Manali Bajpai, CSIR-National Chemical Laboratory, India
Title : Acceptability of mass drug administration for lymphatic filariasis in Baglung municipality of Nepal: A mixed-method study
Muskan Pudasainee, Pokhara University, Nepal